| Revenue growth | Value |
|---|---|
| 1Y (TTM) | -1% |
| 3Y CAGR | +10% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +16% |
| 3Y CAGR | -41% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,651.50 +23.90 (0.52%) | 21,168.16 | 28.79 | 5.04 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,846.00 +125.50 (4.61%) | 20,634.90 | 30.43 | 5.75 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,942.00 +74.00 (1.08%) | 17,175.63 | 101.26 | 19.68 | ||
Natco PharmaNATCOPHARM | ₹838.10 -5.15 (0.61%) | 15,100.75 | 13.19 | 1.64 |